Robert Stone

Robert Stone

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › Centers for Disease Control and Prevention (CDC)

Share:

Health Care Week In Review: CMS Releases Guidance on Medicare Prescription Payment Plan and House Holds a Hearing on 19 Health...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/19/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , Investigational New Drug Application (IND) , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Health Care Week in Review: CMS Announces Data RFI to Improve Medicare Advantage Transparency; Senate Finance Committee Releases...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/29/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Generic Drugs , Health Care Providers , Healthcare Facilities , Hospitals , HRSA , Medicaid , Medicare , Medicare Advantage , National Institute of Health (NIH) , Request For Information

Health Care Week in Review: House E&C Committee Held Mark-Up of 44 Bills, Biden Administration Announced Actions to Lower...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/11/2023  /  Animal Drugs , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: House E&C Subcommittee on Health Held a Hearing on Healthcare and AI; CMS Extended the Application...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/4/2023  /  Artificial Intelligence , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , Life Sciences , Medical Devices , OIG , Popular , SAMHSA

Health Care Week In Review: Senate Finance Committee Advanced Bipartisan Healthcare Legislation, CMS Released Medicare Advantage...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/13/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Medicare , Medicare Advantage , Medicare Part D , Mental Health , Pharmaceutical Industry , Popular , Prescription Drugs , SAMHSA

Health Care Week in Review: CMS Releases Three Major Medicare Final Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/6/2023  /  21st Century Cures Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , DEA , Department of Health and Human Services (HHS) , Final Rules , Health Care Providers , Healthcare Facilities , Medicaid , Medicare , National Institute of Health (NIH) , OIG , Physician Medicare Reimbursements , Popular , Prescription Drugs

Health Care Week In Review: Senators Introduced the Bipartisan Primary Care and Health Workforce Act

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/18/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs

Health Care Week In Review: Lower Cost, More Transparency Act Draft Health Bill Released

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/11/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , National Institute of Health (NIH) , Nursing Homes , OIG

Health Care Week in Review: CMS Announces Details to Pay Drug Costs on Installment Plan

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/29/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare , Medicare Part D , Pharmaceutical Industry , Popular , Prescription Drugs , Vaccinations

Health Care Week In Review: Biden Administration Releases Rules and Awards for Rural Residency Programs

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/1/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Pharmaceutical Industry , Prescription Drugs , Substance Abuse

Health Care Week in Review: PAHPA Reauthorization Bills Receive House and Senate Markups

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/24/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , Infectious Diseases , Medicaid , Medicare , Mental Health , OIG , Popular , SAMHSA , Substance Abuse

Health Care Week in Review: Leqembi Approval, Administration Issues Proposed Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/10/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , Section 340B

Health Care Week in Review: HHS Coverage Flexibilities and MedPAC/MACPAC Reports

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/19/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Popular , Prescription Drugs , Telehealth , Telemedicine

Health Care Week In Review: CMS Issues Proposed Rule, CBO Releases Health Insurance Coverage Projections

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/30/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , Medicaid , Medicare , National Institute of Health (NIH) , OIG , SAMHSA

Health Care Week In Review: COVID-19 PHE Expires, DEA Issues Final Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/15/2023  /  Biologics , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Popular , Prescription Drugs , Public Health Emergency , Telehealth , Telemedicine

Health Care Week In Review: Surgeon General Advisory on Loneliness and EMTALA Requirements

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/8/2023  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Clinical Trials , Department of Health and Human Services (HHS) , EMTALA , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices , National Institute of Health (NIH) , Popular , SAMHSA

Health Care Week In Review: House Passes Debt Limit Bill, CMS Proposes Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/1/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH)

Health Care Week in Review: CMS Issues Proposed and Final Rules and NIH Releases a Cancer Plan

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/10/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , SAMHSA

Health Care Week in Review: Health Care Budget Hearings and Organ System Modernization

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/27/2023  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , SAMHSA

Health Care Week in Review: President’s Budget and ASPR Cybersecurity Guide

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/13/2023  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Popular , Public Health , Public Health Emergency
45 Results
 / 
View per page
« Previous
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide